From the Editor-in-Chief
Patients in this age group have particular needs, and cancer centers are beginning to tailor programs for them.
by William G. Nelson, MD, PhD
Making Cancer Clinical Trials More Inclusive | New Therapies for Metastatic Lung Cancer | Immunotherapy Shows Promise for Treating Brain Metastases | A Strategy to Watch | Older Adults at Risk for Cancer Overscreening | What’s Next?
Your Cancer Guide
Cancer treatments may make having sex difficult, but there are more ways to demonstrate love.
by Hester Hill Schnipper
Caregiving With Confidence
Caregivers can help ensure loved ones feel valued and respected.
by Karen J. Bannan
Continued federal funding to support biomedical research, including cancer research, is vitally important during the pandemic.
by Brandon Leonard, MA, and Marc Johnson, MPP
The pandemic has made telehealth a necessity for many cancer patients. When the crisis clears, these technological tools may improve cancer care in the long term.
by Stephen Ornes
New drugs and drug combinations are helping more patients live longer with advanced kidney cancer. But questions remain about how best to choose among them.
by Kendall K. Morgan
People with cancer that has spread to only a few locations—called oligometastatic cancer—may benefit from aggressive local treatment.
by Kate Yandell
With a renewed sense of purpose, stage IV lung cancer survivor Oswald Peterson returns to his parents’ native Trinidad to celebrate the Caribbean festival.
by Lindsey Konkel
Daily Dose | Exercising at Home
Hematologist-oncologist Vinayak K. Prasad describes his positions on cancer research and policy in a recently published book.
by Marci A. Landsmann
Maintaining relationships through cancer, feeling unappreciated as a caregiver, and finding information that's relevant to young people with cancer.
Inspired by a family friend, Chase Sloan has published a recipe book with proceeds going toward cancer research.
by Erin O'Donnell
Facts and Stats
New treatments in the U.S. are scrutinized in various ways before and after they are approved by the Food and Drug Administration.
People who have inherited BRCA mutations and are at high risk for cancer recurrence may benefit from a PARP inhibitor.
by Pamela Rafalow Grossman
Patients now have full access to their online medical records. What are the benefits and downsides?
by Jen Tota McGivney
After adapting remote patient monitoring programs to cancer patients with COVID-19, cancer centers delve deeper into the programs’ value for cancer patients undergoing treatment.
by Jon Kelvey
The FDA recently expressed a new commitment to testing cancer drugs at lower doses, rather than defaulting to the highest dose most people can tolerate.
by Marcus A. Banks
Authors make a call for anti-racist cancer research.
AACR Dialogues showcase honest discussion about delivering equitable care.
AACR's blog writers provide coverage of the AACR Annual Meeting 2021.
Learning Medicare’s ABCDs
donate to the AACR